Henry Evans


Henry’s patent experience includes helping defend a client’s UK patents in a multi-patent revocation action, prosecution of European applications, and coordination of large global families of applications. Since joining Carpmaels & Ransford, Henry has been busy developing a portfolio with a notable component of biological therapeutics. This includes technologies relating to non-antibody-based protein scaffolds and stem cell-derived therapeutics.

His litigation experience encompasses identifying expert witnesses for UK High Court trials, as well as assisting with preparation of expert witness statements and coordination with parallel opposition appeal proceedings at the EPO.

Henry joined the firm in 2013 as a trainee patent attorney. He graduated from Oxford University with a first class degree in Biological Sciences, majoring in immunology, and cell and molecular biology. His final year dissertation was a bioinformatics analysis of sugar responsive gene regulatory networks. He then spent time as a management and technology consultant for a global consultancy, gaining valuable commercial insights. However on winning a studentship for a Wellcome Trust PhD programme, he returned to Imperial College to undertake research into immunology and infection. Henry’s doctoral research focused on the study of primary human lymphocytes in response to challenge or stress.

During his doctoral studies, he authored several peer-reviewed publications, presented two international conference papers and won an award for being an outstanding PhD student.

Following completion of his PhD, Henry was a postdoctoral research fellow at Harvard’s department of stem cell and regenerative biology. His research focused on the tolerised immune compartment established during pregnancy and how this could direct the development of biological therapeutics. The research was partly funded by a BD Biosciences Immunology research grant, which Henry won in 2012. During his research, he also undertook an internship with an innovation fund investment group specialising in funding spin-out start-ups in biotechnology and medical devices.


  • BA Biological Sciences (University of Oxford)
  • MSc Bioinformatics (Imperial College London)
  • PhD (Immunology; Imperial College London)
  • European Patent Attorney
  • Chartered Patent Attorney